Xiaochen Zhao
158 Xinjunhuan Road
Minhang, 201114, China
Minhang, 201114, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Enhancing physician support in pancreatic cancer diagnosis: New M-F-RCNN artificial intelligence model using endoscopic ultrasound.
Journal: Endoscopy international open
Published: June 27, 2024
ASO Video Abstract: Neoadjuvant Chemo-Immunotherapy Increases Tumor Immune Lymphocytes Infiltration in Resectable NSCLC.
Journal: Annals of surgical oncology
Published: August 24, 2023
Lenvatinib plus anti-PD-1 antibodies as conversion therapy for patients with unresectable intermediate-advanced hepatocellular carcinoma: a single-arm, phase II trial.
Journal: Journal for immunotherapy of cancer
Published: August 08, 2023
ASO Author Reflections: Immune Microenvironment Indicators in Neoadjuvant Chemo-Immunotherapy.
Journal: Annals of surgical oncology
Published: July 28, 2023
PD-1/PD-L1 Inhibitor Plus Chemotherapy Versus PD-1/PD-L1 Inhibitor in Microsatellite Instability Gastrointestinal Cancers: A Multicenter Retrospective Study.
Journal: JCO precision oncology
Published: March 30, 2023
Integrating machine learning algorithms to systematically assess reactive oxygen species levels to aid prognosis and novel treatments for triple -negative breast cancer patients.
Journal: Frontiers in immunology
Published: March 29, 2023
Association between homologous recombination deficiency and outcomes with platinum and platinum-free chemotherapy in patients with triple-negative breast cancer.
Journal: Cancer biology & medicine
Published: March 02, 2023
Neoadjuvant sintilimab in combination with concurrent chemoradiotherapy for locally advanced gastric or gastroesophageal junction adenocarcinoma: a single-arm phase 2 trial.
Journal: Nature communications
Published: December 14, 2022
Neoadjuvant Chemoimmunotherapy Increases Tumor Immune Lymphocytes Infiltration in Resectable Non-small Cell Lung Cancer.
Journal: Annals of surgical oncology
Published: November 22, 2022
Development and validation of postoperative circulating tumor DNA combined with clinicopathological risk factors for recurrence prediction in patients with stage I-III colorectal cancer.
Journal: Journal of translational medicine
Published: October 18, 2022
China special issue on gastrointestinal tumors-NTRK fusion in a large real-world population and clinical utility of circulating tumor DNA genotyping to guide TRK inhibitor treatment.
Journal: International journal of cancer
Published: September 16, 2022
Last Updated: 09/26/2026